Target Price | $389.00 |
Price | $359.10 |
Potential | 8.33% |
Number of Estimates | 21 |
21 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $389.00. This is 8.33% higher than the current stock price. The highest price target is $420.00 16.96% , the lowest is $289.00 19.52% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Sherwin-Williams to buy, 11 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 8.33% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
23 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.5b . This is 1.84% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.0b 4.28% , the lowest is $23.1b 0.39% .
This results in the following potential growth metrics:
2024 | $23.1b | 0.20% |
---|---|---|
2025 | $23.5b | 1.57% |
2026 | $24.6b | 4.92% |
2027 | $25.9b | 5.31% |
2028 | $26.8b | 3.57% |
23 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.7b . This is 5.61% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 10.92% , the lowest is $4.4b 1.79% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.1b | 3.32% |
---|---|---|
2025 | $4.7b | 7.24% |
2026 | $5.1b | 8.42% |
2027 | $5.6b | 8.89% |
2028 | $5.8b | 5.04% |
2024 | 17.70% | 3.52% |
---|---|---|
2025 | 20.11% | 5.61% |
2026 | 20.78% | 3.33% |
2027 | 21.48% | 3.37% |
2028 | 21.79% | 1.44% |
11 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.8b . This is 5.60% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 12.57% , the lowest is $2.6b 3.60% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.6b | 14.05% |
---|---|---|
2025 | $2.8b | 5.80% |
2026 | $3.2b | 13.44% |
2027 | $3.6b | 13.41% |
2028 | $3.7b | 3.47% |
2024 | 11.45% | 13.82% |
---|---|---|
2025 | 11.92% | 4.14% |
2026 | 12.89% | 8.14% |
2027 | 13.88% | 7.68% |
2028 | 13.87% | 0.07% |
11 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.16 . This is 5.58% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.90 12.58% , the lowest is $10.19 3.60% .
This results in the following potential growth metrics and future valuations:
2024 | $10.55 | 14.05% |
---|---|---|
2025 | $11.16 | 5.78% |
2026 | $12.66 | 13.44% |
2027 | $14.36 | 13.43% |
2028 | $14.86 | 3.48% |
Current | 33.98 | 1.95% |
---|---|---|
2025 | 32.17 | 5.33% |
2026 | 28.36 | 11.84% |
2027 | 25.00 | 11.85% |
2028 | 24.17 | 3.32% |
Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.37 and an P/S ratio of 3.84 .
This results in the following potential growth metrics and future valuations:
Current | 4.45 | 11.53% |
---|---|---|
2025 | 4.37 | 1.72% |
2026 | 4.17 | 4.68% |
2027 | 3.96 | 5.04% |
2028 | 3.82 | 3.45% |
Current | 3.91 | 13.32% |
---|---|---|
2025 | 3.84 | 1.81% |
2026 | 3.66 | 4.68% |
2027 | 3.47 | 5.04% |
2028 | 3.35 | 3.45% |
Sherwin-Williams...
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | May 01 2025 |
Wells Fargo |
Equal-Weight
➜
Overweight
|
Upgrade | Apr 30 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 22 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 09 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 08 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
May 01 2025 |
Upgrade
Wells Fargo:
Equal-Weight
➜
Overweight
|
Apr 30 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 22 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 09 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 08 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.